Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonah C Meltzer

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Brain : a Journal of Neurology|December 27, 2021
APOE4 derived from astrocytes leads to blood-brain barrier impairmentRosemary J Jackson, Jonah C Meltzer, Huong Nguyen, et al.
Brain : a Journal of Neurology|November 6, 2024
Tau, synapse loss and gliosis progress in an Alzheimer's mouse model after amyloid-β immunotherapyLindsay A Welikovitch, Anastasie Mate de Gerando, Anita Khasnavis, et al.
Learning Health Systems|June 17, 2024
Determinants of remote measurement-based care uptake in a safety net outpatient psychiatry department as part of learning health system transitionRajendra Aldis, Lisa C Rosenfeld, Norah Mulvaney-Day, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
APOE2 gene therapy reduces amyloid deposition, and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer diseaseRosemary J Jackson, Megan S Keiser, Jonah C Meltzer, et al.
Molecular Therapy. Methods & Clinical Development|December 3, 2019
Selection of an Efficient AAV Vector for Robust CNS Transgene ExpressionKillian S Hanlon, Jonah C Meltzer, Tetyana Buzhdygan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 20, 2024
APOE2 gene therapy reduces amyloid deposition and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer diseaseRosemary J Jackson, Megan S Keiser, Jonah C Meltzer, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Brain : a Journal of Neurology|December 27, 2021
APOE4 derived from astrocytes leads to blood-brain barrier impairmentRosemary J Jackson, Jonah C Meltzer, Huong Nguyen, et al.
Brain : a Journal of Neurology|November 6, 2024
Tau, synapse loss and gliosis progress in an Alzheimer's mouse model after amyloid-β immunotherapyLindsay A Welikovitch, Anastasie Mate de Gerando, Anita Khasnavis, et al.
Learning Health Systems|June 17, 2024
Determinants of remote measurement-based care uptake in a safety net outpatient psychiatry department as part of learning health system transitionRajendra Aldis, Lisa C Rosenfeld, Norah Mulvaney-Day, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
APOE2 gene therapy reduces amyloid deposition, and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer diseaseRosemary J Jackson, Megan S Keiser, Jonah C Meltzer, et al.
Molecular Therapy. Methods & Clinical Development|December 3, 2019
Selection of an Efficient AAV Vector for Robust CNS Transgene ExpressionKillian S Hanlon, Jonah C Meltzer, Tetyana Buzhdygan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 20, 2024
APOE2 gene therapy reduces amyloid deposition and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer diseaseRosemary J Jackson, Megan S Keiser, Jonah C Meltzer, et al.
Pageof 1